Developing and Marketing an FDA-Regulated Test
Exact Sciences overcame significant obstacles to bring cancer screening innovation to patients.
Read MorePosted by Elaine Sanchez Wilson | Feb 9, 2016 | Cancer, Microbiology Instruments, Molecular Diagnostics |
Exact Sciences overcame significant obstacles to bring cancer screening innovation to patients.
Read MorePosted by Steve Halasey | Feb 1, 2016 | Company News, Molecular Diagnostics, Prenatal Testing |
Acquisition gives PE access to an innovative noninvasive prenatal testing solution under development, expanding the company’s maternal–fetal health portfolio.
Read MorePosted by Elaine Sanchez Wilson | Jan 31, 2016 | Cerebrovascular, Flow Cytometry, Flow Cytometry Instruments, Flow Cytometry Reagents & Test Kits, Library Preparation Systems Flow, Stroke |
Lab professionals can expect that flow cytometry will continue to evolve in new directions with even greater utility for clinical testing.
Read MorePosted by Elaine Sanchez Wilson | Jan 19, 2016 | Cancer, Unknown Origin & Other Cancer Types |
In this month’s Inside Track, Nadia Altomare, CEO of Abcodia, discusses how her company’s test can lead to improved clinical outcomes.
Read MorePosted by Elaine Sanchez Wilson | Jan 18, 2016 | Uncategorized |
The suits involve the use of cell-free fetal DNA for noninvasive prenatal testing.
Read More